Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


Read more


MC Services successfully attended a variety of conferences in the first months of 2017


With participation in a number of conferences all over Europe, MC Services made a successful start into 2017. For a list of attended conferences and some impressions visit us on Facebook.


Read more


MC Services AG is supporting BIO-Europe & German Equity Forum as media partner


BIO-Europe 2017 


Organized by EBD Group, the 23rd annual BIO-Europe will this year take place in Berlin, Germany, from November 6 to 8, 2017. As Europe's largest life science partnering conference, BIO-Europe is the "must-attend" event offering opportunities for those involved in the biotech industry to network, bringing together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more.


As media partner, MC Services invites both local and international journalist to the event and keeps them informed on the presenting company executives and attending investors. Additional Information on MC Services’ engagement and activities during the conference will be announced soon.


Learn more

German Equity Forum 2017


MC Services AG is again supporting this year’s German Equity Forum, taking place from November 27-29, as media partner.  According to the slogan "Entrepreneurs meet investors" the Deutsche Börse AG has organized the German Equity Forum since 1996, which has evolved into one of the most important and significant capital market events in corporate finance in Europe. Last year alone, around 3,000 1on1 meetings and 200 analysts' conferences took place. The 3-day program features panel discussions, presentations and workshops on current market developments in corporate financing and the capital market.


Learn more

RedHill Biopharma Reports 2017 Second Quarter Financial Results


PeproStat Phase IIb study passes recruitment mid-point ahead of schedule – Top line results brought forward to Q4 2017


Adocia presents first half 2017 financial results 


Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay  to Detect Zika Virus Infection


Amendment to Amphion Innovations Consultancy Agreement


 NOXXON issues first tranche of ODIRNANE bonds


4SC licenses Kv1.3 inhibitors to Maruho


RedHill Biopharma Announces Last Patient Visit in BEKINDA(R) Phase II Study for IBS-D


ABIVAX to present latest clinical data on ABX464 at the International Aids Society Conference in Paris, France


WILEX reports first half 2017 results